North America Obesity Intervention Devices (Gastric Bands, Gastric Balloon, Gastric Stimulation System) Market Size, Share & Industry Trends Analysis Report 2023-2029
August 23, 2023 04:28 ET
|
Research and Markets
Dublin, Aug. 23, 2023 (GLOBE NEWSWIRE) -- The "North America Obesity Intervention Devices Market Size, Share & Industry Trends Analysis Report By End User (Hospitals and Clinics & Others),...
Worldwide Gastric Balloons and Bands Industry to 2027 - Technological Advancements in Devices and Procedures Presents Opportunities
August 13, 2021 07:58 ET
|
Research and Markets
Dublin, Aug. 13, 2021 (GLOBE NEWSWIRE) -- The "Gastric Balloons and Bands Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027" report has been added to...
Worldwide Bariatric Surgery Devices Industry to 2026 - Featuring GI Dynamics, Covidien and Allergan Among Others
July 16, 2021 05:13 ET
|
Research and Markets
Dublin, July 16, 2021 (GLOBE NEWSWIRE) -- The "Bariatric Surgery Devices Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026" report has been added to...
Insights on the Bariatric Surgery Global Market to 2025 - by Service/Device Type, End-user and Region
April 29, 2021 06:13 ET
|
Research and Markets
Dublin, April 29, 2021 (GLOBE NEWSWIRE) -- The "Bariatric Surgery: Global Markets for Services and Devices 2020-2025" report has been added to ResearchAndMarkets.com's offering. This report aims...
Worldwide Intragastric Balloon Market to 2026 - Industry Analysis and Forecast
September 28, 2020 06:49 ET
|
Research and Markets
Dublin, Sept. 28, 2020 (GLOBE NEWSWIRE) -- The "Global Intragastric Balloon Market By Administration, By Type, By Filling Material, By End Use, By Region, Industry Analysis and Forecast, 2020 -...
Obalon Announces Consulting Agreement As Part of Strategy To Seek Coverage and Reimbursement for The Obalon Balloon System
August 13, 2020 07:00 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...
Obalon Announces First Quarter 2020 Financial Results and Business Update
June 19, 2020 06:15 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, June 19, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...
Obalon Announces Further Impacts Related To Covid-19 Crisis and Current Business Environment
May 11, 2020 08:30 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, May 11, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and...
William Plovanic Resigns as President and Chief Executive Officer and Will Continue to Serve Solely as Director
May 08, 2020 08:00 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, May 08, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved...
Obalon Gas-Filled Balloon Not Subject of Fourth FDA Letter to Health Care Providers Related To Serious Risks, Including Death, With Liquid-Filled Intragastric Balloons
April 28, 2020 09:00 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, April 28, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...